Earum Pharmaceuticals Limited
Fixed Price IPO · BSE
- Price band
- ₹36 - ₹36
- Lot size
- 3,000 shares
- Issue amount
- ₹7 cr
- Total subscription
- 0×
- Opens
- 21 Jun 2019
- Closes
- 26 Jun 2019
- Allotment
- 1 Jul 2019
- Listing
- 4 Jul 2019
Offer at a glance
Issue overview
- Issue size
- 18,48,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,08,000
- Fresh issue
- ₹0 cr
- Offer for sale
- ₹0 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- BSE
- Maximum investment
- ₹1,08,000
- Issue type
- Fixed Price IPO
- Shares before issue
- 43,19,910
- Shares after issue
- 61,67,910
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 3,000 | ₹1,08,000 |
| HNI | 2 | 6,000 | ₹2,16,000 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
in Lakhs · Reported periods may include interim results.
Company information
Company profile
Incorporated in 2012, Ahmedabad-based Earum Pharmaceuticals Limited is engaged in the trading, marketing, and distribution of pharmaceutical formulation products, with a portfolio of around 125 formulations including multivitamins, gynaecology drugs, steroids, antibiotics, cerebral activators, and gastrointestinal medicines. The company is also involved in trading active pharmaceutical ingredients such as Amoxicillin Trihydrate IP, Levofloxacin Hemihydrate IP, and Albendazole IP, and operates through two main business models—marketing its own branded formulations and trading generic formulations of other brands, with about 24 products manufactured by third parties and sold under its own brand. Earum Pharmaceuticals operates a well-equipped warehouse in Ahmedabad, Gujarat, and has a presence in both domestic and international markets including South East Asia, Latin America, and Africa, while focusing on expanding its global footprint, improving market capabilities, and maintaining high-quality product standards.
Strengths
- Wide Product Range: Offers a broad selection of products.
- Experienced Promoter: Backed by 11+ years of industry experience.
- Quality Assurance: Maintains high quality standards.
Promoters
Mr. Bhumishth Narendrabhai Patel
Mrs. Payal Bhumishth Patel
Registrar & documents
Lead manager
Hem Securities Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
G1, Ground Floor, V R Complex, Near Sanathal Cross Road, SP Ring Road, Sanathal, Ahmedabad, Gujarat-382210,
+91-79-48402525
[email protected]Company website ↗Frequently Asked Questions
What is Earum Pharmaceuticals IPO GMP today?
Currently, Earum Pharmaceuticals IPO Grey Market Premium (GMP) is trading around ₹0 or awaiting active buyer-seller quotes in the grey market. The issue price is set at ₹36. Track daily updates on IPO Premiums as bidding numbers unfold.
What is the lot size and minimum investment for Earum Pharmaceuticals IPO?
The minimum bid lot size for Earum Pharmaceuticals IPO is 3,000 shares. At the cut-off price of ₹36 per share, retail investors need a minimum application amount of ₹1,08,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).
When will Earum Pharmaceuticals IPO allotment status be announced?
The allotment status for Earum Pharmaceuticals IPO is scheduled to be finalized on 1 Jul 2019. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Bigshare Services Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Earum Pharmaceuticals IPO allotment status online by PAN?
To check Earum Pharmaceuticals IPO allotment status: 1) Visit the registrar portal (Bigshare Services Private Limited) or the BSE IPO allotment page. 2) Select 'Earum Pharmaceuticals Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.